A Sensitive and Improved Throughput UPLC-MS/MS Quantitation Method of Total Cytochrome P450 Mediated Arachidonic Acid Metabolites That Can Separate Regio-isomers and Cis/trans-EETs from Human Plasma

Overview

Journal Chem Phys Lipids

Specialty Biochemistry

Date 2018 Sep 12

PMID 30201384

Citations 2

Authors

Maxwell Zeigler

Dale Whittington

Nona Sotoodehnia

Rozenn N Lemaitre

Rheem A Totah

Affiliations

Soon will be listed here.

Abstract

A method for the detection and quantification of hydroxyl and epoxy arachidonic acid (AA) metabolites in human plasma was developed using liquid-liquid extraction, phospholipid saponification followed by derivatization of the acid moiety and liquid chromatographic tandem mass spectrometric detection. Derivatization with a pyridinium analog allowed for detection in the positive ion mode, greatly improving sensitivity and the stability of the more labile AA metabolites. The entire method utilizes a 96-well plate format, increasing sample throughput, and was optimized to measure 5-, 8-, 9-, 11-, 12-, 15-, 19-, and 20- hydroxyeicosatetraenoic acid (HETE), 5,6-, 8,9-, 11,12-, and 14,15- dihydroxyeicosatrienoic acid (DHET), and the regio- and cis-/ trans- isomers of 5,6-, 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acid (EET). The method was validated for its applicability over the FA concentration range found in human plasma. Using 100 μL aliquots of pooled human plasma, EET levels, particularly 5,6-EET, were observed to be higher than previously reported, with measured concentrations of 23.6 ng/ml for 5,6-EET, 5.6 ng/mL for 5,6-trans-EET, 8.0 ng/mL for 8,9-EET, 1.9 ng/mL for 8,9-trans-EET, 8.8 ng/mL for 11,12-EET, 3.4 ng/mL for 11,12-trans-EET, 10.7 ng/mL for 14,15-EET, and 1.7 ng/mL 14,15-trans- EET. This method is suitable for large population studies to elucidate the complex interactions between the eicosanoids and various disease states and may be used for quantitation of a wide variety of fattyacids beyond eicosanoids from small volumes of human plasma.

Citing Articles

A sensitive LC-MS/MS method for the quantification of serum epoxyeicosatrienoic and dihydroxyeicosatrienoic acids in the identification of diabetic kidney disease.

Liu Y, Huang A, Jiang Y, Kong X, Zhao M, Gao P Anal Bioanal Chem. 2025; .

PMID: 39976686 DOI: 10.1007/s00216-025-05798-z.

Habitual Intake of Marine-Derived n-3 PUFAs is Inversely Associated with a Cardiometabolic Inflammatory Profile in Yup'ik Alaska Native People.

Boyer B, Hopkins S, Wiener H, Purnell J, OBrien D, Zhang C J Nutr. 2021; 152(3):844-855.

PMID: 34871429 PMC: 8891177. DOI: 10.1093/jn/nxab412.

Changes in erythrocyte membrane epoxyeicosatrienoic, dihydroxyeicosatrienoic, and hydroxyeicosatetraenoic acids during pregnancy.

Somani S, Zeigler M, Fay E, Leahy M, Bermudez B, Totah R Life Sci. 2020; 264:118590.

PMID: 33069736 PMC: 7755749. DOI: 10.1016/j.lfs.2020.118590.

References

Fulton D, Falck J, McGiff J, Carroll M, Quilley J . A method for the determination of 5,6-EET using the lactone as an intermediate in the formation of the diol. J Lipid Res. 1998; 39(8):1713-21. View

Balsinde J, Winstead M, Dennis E . Phospholipase A(2) regulation of arachidonic acid mobilization. FEBS Lett. 2002; 531(1):2-6. DOI: 10.1016/s0014-5793(02)03413-0. View

Zeldin D, Kobayashi J, Falck J, Winder B, Hammock B, Snapper J . Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase. J Biol Chem. 1993; 268(9):6402-7. View

Jiang H, McGiff J, Quilley J, Sacerdoti D, Reddy L, Falck J . Identification of 5,6-trans-epoxyeicosatrienoic acid in the phospholipids of red blood cells. J Biol Chem. 2004; 279(35):36412-8. DOI: 10.1074/jbc.M403962200. View

Yue H, Strauss K, Borenstein M, Barbe M, Rossi L, Jansen S . Determination of bioactive eicosanoids in brain tissue by a sensitive reversed-phase liquid chromatographic method with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2004; 803(2):267-77. DOI: 10.1016/j.jchromb.2003.12.027. View

Katoh T, Takahashi K, Capdevila J, Karara A, Falck J, Jacobson H . Glomerular stereospecific synthesis and hemodynamic actions of 8,9-epoxyeicosatrienoic acid in rat kidney. Am J Physiol. 1991; 261(4 Pt 2):F578-86. DOI: 10.1152/ajprenal.1991.261.4.F578. View

Falck J, Reddy L, Reddy Y, Bondlela M, Krishna U, Ji Y . 11,12-epoxyeicosatrienoic acid (11,12-EET): structural determinants for inhibition of TNF-alpha-induced VCAM-1 expression. Bioorg Med Chem Lett. 2003; 13(22):4011-4. DOI: 10.1016/j.bmcl.2003.08.060. View

Zghibeh C, Gopal V, Poff C, Falck J, Balazy M . Determination of trans-arachidonic acid isomers in human blood plasma. Anal Biochem. 2004; 332(1):137-44. DOI: 10.1016/j.ab.2004.04.030. View

Bollinger J, Naika G, Rohan G, Sadilek M, Gelb M . LC/ESI-MS/MS detection of FAs by charge reversal derivatization with more than four orders of magnitude improvement in sensitivity. J Lipid Res. 2013; 54(12):3523-30. PMC: 3826698. DOI: 10.1194/jlr.D040782. View

10.

Roman R . P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev. 2002; 82(1):131-85. DOI: 10.1152/physrev.00021.2001. View

11.

Yang W, Adamec J, Regnier F . Enhancement of the LC/MS analysis of fatty acids through derivatization and stable isotope coding. Anal Chem. 2007; 79(14):5150-7. DOI: 10.1021/ac070311t. View

12.

Campbell W, Gebremedhin D, Pratt P, Harder D . Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res. 1996; 78(3):415-23. DOI: 10.1161/01.res.78.3.415. View

13.

Yi X, Wu L, Liao D, Wang C, Zhang B . Interactions Among CYP2C8, EPHX2, and CYP4A11 Variants and CYP Plasma Metabolite Levels in Ischemic Stroke. J Atheroscler Thromb. 2016; 23(11):1286-1293. PMC: 5065934. DOI: 10.5551/jat.35279. View

14.

Lange A, Gebremedhin D, Narayanan J, Harder D . 20-Hydroxyeicosatetraenoic acid-induced vasoconstriction and inhibition of potassium current in cerebral vascular smooth muscle is dependent on activation of protein kinase C. J Biol Chem. 1997; 272(43):27345-52. DOI: 10.1074/jbc.272.43.27345. View

15.

Jiang R, Jiao Y, Zhang P, Liu Y, Wang X, Huang Y . Twin Derivatization Strategy for High-Coverage Quantification of Free Fatty Acids by Liquid Chromatography-Tandem Mass Spectrometry. Anal Chem. 2017; 89(22):12223-12230. DOI: 10.1021/acs.analchem.7b03020. View

16.

Deng Y, Theken K, Lee C . Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation. J Mol Cell Cardiol. 2009; 48(2):331-41. PMC: 2813356. DOI: 10.1016/j.yjmcc.2009.10.022. View

17.

Capdevila J, Falck J, Harris R . Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase. J Lipid Res. 2000; 41(2):163-81. View

18.

Axelrod J, Burch R, Jelsema C . Receptor-mediated activation of phospholipase A2 via GTP-binding proteins: arachidonic acid and its metabolites as second messengers. Trends Neurosci. 1988; 11(3):117-23. DOI: 10.1016/0166-2236(88)90157-9. View

19.

Bollinger J, Thompson W, Lai Y, Oslund R, Hallstrand T, Sadilek M . Improved sensitivity mass spectrometric detection of eicosanoids by charge reversal derivatization. Anal Chem. 2010; 82(16):6790-6. PMC: 2959116. DOI: 10.1021/ac100720p. View

20.

Mesaros C, Blair I . Targeted chiral analysis of bioactive arachidonic Acid metabolites using liquid-chromatography-mass spectrometry. Metabolites. 2014; 2(2):337-65. PMC: 3901208. DOI: 10.3390/metabo2020337. View